Loading organizations...
Key people at Junson Capital.
Junson Capital is a single-family office based in Hong Kong, Hong Kong SAR, China, managing a diversified portfolio across real estate, private equity, public markets, and alternative investments. The firm focuses on long-term value creation through disciplined asset allocation and active portfolio management for family wealth preservation and growth. Leveraging expertise in regional and global opportunities, its investments include luxury properties, office buildings, and mixed-use developments, primarily serving clients located in China. With an employee count ranging from 10 to 50, Junson Capital's permanent capital model generates returns through strategic placements in various asset classes. The firm does not publicly disclose specific lead investors or portfolio companies. Founded in 2010, the organization operates without a publicly named founder. Its business model centers on anchored by permanent capital as a single-family office, generates returns through investments in real estate, private equity, and capital markets.
Key people at Junson Capital.
Junson Capital has 7 tracked investments across 7 companies. The latest tracked deal is $23.0M Series B in Corsair Pharma in September 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2023 | Corsair Pharma | $23.0M Series B | NEW Rhein Healthcare Investors | Midas Capital, Plaisance Capital Management, Primavera Capital Group |
| Jul 28, 2022 | BridGene Biosciences | $38.5M Series B | Dyee Capital, Junson Capital, Lapam Capital | — |
| Jul 20, 2021 | Leo Cancer Care | $25.3M Series B | — | Alumni Ventures, CHC, Cosylab, Pureland Global Venture, Radiation Business Solutions, Serra Ventures, Toret Devices, Warf Ventures, YU Galaxy |
| Jun 11, 2020 | WiBotic | $5.7M Series A | — | Aves Capital, Rolling BAY Ventures, SV Tech Ventures, The W Fund, WRF Capital |
| Dec 8, 2019 | RaySecur | $3.0M Seed | Semyon Dukach | Dreamit Ventures, Launchpad Venture Group |
| Oct 15, 2019 | Ansun BioPharma | $7.9M Series B | Junson Capital, Korea Investment Partners, Oceanpine Capital | — |
| May 16, 2019 | MultiVu | $7.0M Seed | Cardumen Capital, Junson Capital, ELI NIR | — |